Clinical Trial Update: Caffeine Citrate in Preterm Infants at Risk of Apnea in Zambia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in Zambia evaluating caffeine citrate to prevent apnea in premature infants is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea of Prematurity

Drugs mentioned

• Caffeine citrate (caffeine citrate)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Premature Infant Disease, Apnea of Prematurity | Phase 4 | Status: NOT_YET_RECRUITING